Chiesi Farmaceutici

Chiesi, an international biopharmaceutical Group focused on R&D and headquartered in Parma, with 31 affiliates worldwide, has released its 2024 Sustainability Report.
The document reaffirms the company’s long-term commitment to responsible business practices. It highlights significant investments and measurable progress across four strategic impact areas: Patients, Planet, People and Prosperity.

We partnered with Chiesi Farmaceutici on the ideation and development of the 2024 Sustainability Report.
This flagship document sits at the heart of the sustainability reporting framework and is designed as a system of complementary outputs, each with a clear thematic focus.

The result is an editorial and visual project that makes sustainability easy to read, coherent and fully embedded in the Group’s overall strategy.

The concept takes shape through a clean, immediately recognisable visual language.
Its goal is to make purpose tangible and guide the reader seamlessly through the sustainability narrative.

The report is defined by the hexagon.
Beyond recalling the pictogram in the Chiesi logo, it frames people, contexts and situations, evoking the gesture of an embrace. This visual element conveys inclusiveness, support and shared responsibility, while structuring the entire graphic system.

The project also expanded into a set of in-depth publications: the ESG Report, the Climate Transition Plan and Chiesi in a Nutshell.
All documents were developed in continuity with the core concept, using colour variations drawn from the Chiesi palette. This approach ensures consistency, clarity and visual alignment across the annual reporting ecosystem.

The outcome is an integrated system that strengthens sustainability storytelling as a concrete, measurable commitment with a clear long-term vision.